Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001415889-22-006475
Filing Date
2022-06-13
Accepted
2022-06-13 16:05:14
Documents
1
Period of Report
2022-06-09

Document Format Files

Seq Description Document Type Size
1 form4-06132022_040601.html 4  
1 form4-06132022_040601.xml 4 3964
  Complete submission text file 0001415889-22-006475.txt   5385
Mailing Address C/O AEGLEA BIOTHERAPEUTICS, INC. 901 S. MOPAC EXPWY, STE. 250 AUSTIN TX 78746
Business Address
Quinn Anthony G. (Reporting) CIK: 0001532219 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-39319 | Film No.: 221011611

Mailing Address 301 BINNEY STREET CAMBRIDGE MA 02142
Business Address 301 BINNEY STREET CAMBRIDGE MA 02142 857-529-5908
Generation Bio Co. (Issuer) CIK: 0001733294 (see all company filings)

EIN.: 814301281 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations